These observations suggest that altered Sirt1 activity through changed intracellular localization and interaction with Ccar2 is important in different stages of pancreatic cancer development, revealing potential therapeutic opportunities. The gene discussed is CCAR2; the disease is familial pancreatic carcinoma.